1887

Abstract

is an opportunistic pathogen and a leading cause of morbidity and premature mortality in patients with medical device-related infections, which is a concern in hospitalized patients. Developing a strategy to raise opsonic antibodies against polysaccharide intracellular adhesin (PIA) could be promising for the elimination of colonizing and biofilm-forming . Following the purification of truncated rSesC protein and PIA, for the first time, PIA was conjugated to rSesC as a carrier to increase the immunogenicity of PIA and its efficacy in mice was evaluated. The structure of the conjugate was analysed using the Fourier transform infrared spectroscopy (FTIR) and proton nuclear magnetic resonance spectroscopy (H1- NMR) methods. Afterwards, the immune response was evaluated by measuring the total IgG, IgG2a and IgG2b titres.

The immunization of mice with the PIA–rSesC conjugate raised the levels of opsonic antibodies, and the vaccinated mice were protected when challenged intravenously by wild-type strain 1457. Further studies indicated that the conjugated vaccine was able to eliminate biofilm formation in or assays.

This study confirms the proposal that the immunization of mice with PIA-rSesC conjugate vaccine could protect against infection.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000910
2019-05-01
2024-12-07
Loading full text...

Full text loading...

/deliver/fulltext/jmm/68/5/791.html?itemId=/content/journal/jmm/10.1099/jmm.0.000910&mimeType=html&fmt=ahah

References

  1. Goldmann DA, Pier GB. Pathogenesis of infections related to intravascular catheterization. Clin Microbiol Rev 1993; 6:176–192 [View Article]
    [Google Scholar]
  2. Lebeaux D, Chauhan A, Rendueles O, Beloin C. From in vitro to in vivo models of bacterial biofilm-related Infections. Pathogens 2013; 2:288–356 [View Article]
    [Google Scholar]
  3. Mousavi SF, Mirzaei B, Shaghaghi B, Jalali P, Setayesh T et al. Phenotypic and genotypic features of first biofilm forming nasopharyngeal colonized Streptococcus pneumoniae isolates. Iran J Microbiol 2017; 9:200
    [Google Scholar]
  4. Shahrooei M, Hira V, Stijlemans B, Merckx R, Hermans PW et al. Inhibition of Staphylococcus epidermidis biofilm formation by rabbit polyclonal antibodies against the SesC protein. Infect Immun 2009; 77:3670–3678 [View Article]
    [Google Scholar]
  5. Costerton JW, Montanaro L, Arciola CR. Biofilm in implant infections: its production and regulation. Int J Artif Organs 2005; 28:1062–1068 [View Article]
    [Google Scholar]
  6. Mirzaei B, Babaei R, Asiabar AP, Bameri Z. Detection of both vanA & vanB genes in vanA phenotypes of Enterococci by Taq Man RT-PCR. Braz J Microbiol 2015; 46:161–165 [View Article]
    [Google Scholar]
  7. del Pozo JL, Patel R. The challenge of treating biofilm-associated bacterial infections. Clin Pharmacol Ther 2007; 82:204–209 [View Article]
    [Google Scholar]
  8. Hira V, Kornelisse RF, de Groot R, Hermans PW. Prevention of coagulase-negative staphylococcal late-onset sepsis in neonates. Challenges in the prevention of coagulase-negative staphylococcal sepsis in neonates 109:
    [Google Scholar]
  9. Shahrooei M, Hira V, Khodaparast L, Khodaparast L, Stijlemans B et al. Vaccination with SesC decreases Staphylococcus epidermidis biofilm formation. Infect Immun 2012; 80:3660–3668 [View Article]
    [Google Scholar]
  10. Ziebuhr W, Krimmer V, Rachid S, Lössner I, Götz F et al. A novel mechanism of phase variation of virulence in Staphylococcus epidermidis: evidence for control of the polysaccharide intercellular adhesin synthesis by alternating insertion and excision of the insertion sequence element IS256. Mol Microbiol 1999; 32:345–356 [View Article]
    [Google Scholar]
  11. Raad I, Alrahwan A, Rolston K. Staphylococcus epidermidis : emerging resistance and need for alternative agents. Clin Infect Dis 1998; 26:1182–1187 [View Article]
    [Google Scholar]
  12. Otto M. Staphylococcus epidermidis — the 'accidental' pathogen. Nat Rev Micro 2009; 7:555–567 [View Article]
    [Google Scholar]
  13. Rogers KL, Fey PD, Rupp ME. Coagulase-negative staphylococcal infections. Infect Dis Clin North Am 2009; 23:73–98 [View Article]
    [Google Scholar]
  14. Cramton SE, Gerke C, Schnell NF, Nichols WW, Götz F. The intercellular adhesion (ica) locus is present in Staphylococcus aureus and is required for biofilm formation. Infect Immun 1999; 67:5427–5433
    [Google Scholar]
  15. Gerke C, Kraft A, Süßmuth R, Schweitzer O, Götz F. Characterization of the N -Acetylglucosaminyltransferase activity involved in the Biosynthesis of the Staphylococcus epidermidis polysaccharide intercellular Adhesin . J Biol Chem 1998; 273:18586–18593 [View Article]
    [Google Scholar]
  16. Mack D, Fischer W, Krokotsch A, Leopold K, Hartmann R et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1, 6-linked glucosaminoglycan: purification and structural analysis. J Bacteriol 1996; 178:175–183 [View Article]
    [Google Scholar]
  17. Fitzpatrick F, Humphreys H, O'Gara JP. Evidence for icaADBC-independent biofilm development mechanism in methicillin-resistant Staphylococcus aureus clinical isolates. J Clin Microbiol 2005; 43:1973–1976 [View Article]
    [Google Scholar]
  18. Hennig S, Nyunt Wai S, Ziebuhr W. Spontaneous switch to PIA-independent biofilm formation in an ica-positive Staphylococcus epidermidis isolate. Int J Med Microbiol 2007; 297:117–122 [View Article]
    [Google Scholar]
  19. Cerca N, Jefferson KK, Oliveira R, Pier GB, Azeredo J. Comparative antibody-mediated phagocytosis of Staphylococcus epidermidis cells grown in a biofilm or in the planktonic state. Infect Immun 2006; 74:4849–4855 [View Article]
    [Google Scholar]
  20. Maira-Litrán T, Kropec A, Abeygunawardana C, Joyce J, Mark G et al. Immunochemical properties of the staphylococcal poly-N-acetylglucosamine surface polysaccharide. Infect Immun 2002; 70:4433–4440 [View Article]
    [Google Scholar]
  21. Bowden MG, Chen W, Singvall J, Xu Y, Peacock SJ. Identification and preliminary characterization of cell-wall-anchored proteins of Staphylococcus epidermidis . mBio 2005; 151:1453–1464 [View Article]
    [Google Scholar]
  22. Götz F. Staphylococci in colonization and disease: prospective targets for drugs and vaccines. Curr Opin Microbiol 2004; 7:477–487 [View Article]
    [Google Scholar]
  23. Sellman BR, Howell AP, Kelly-Boyd C, Baker SM. Identification of immunogenic and serum binding proteins of Staphylococcus epidermidis . Infect Immun 2005; 73:6591–6600 [View Article]
    [Google Scholar]
  24. Mack D, Nedelmann M, Krokotsch A, Schwarzkopf A, Heesemann J et al. Characterization of transposon mutants of biofilm-producing Staphylococcus epidermidis impaired in the accumulative phase of biofilm production: genetic identification of a hexosamine-containing polysaccharide intercellular adhesin. Infect Immun 1994; 62:3244–3253
    [Google Scholar]
  25. Mirzaei B, Moosavi SF, Babaei R, Siadat SD, Vaziri F et al. Purification and evaluation of Polysaccharide Intercellular Adhesion (PIA) antigen from Staphylococcus epidermidis . Curr Microbiol 2016; 73:611–617 [View Article]
    [Google Scholar]
  26. Smith RL, Gilkerson E. Quantitation of glycosaminoglycan hexosamine using 3-methyl-2-benzothiazolone hydrazone hydrochloride. Anal Biochem 1979; 98:478–480 [View Article]
    [Google Scholar]
  27. Bao J, Chen W, Liu T, Zhu Y, Jin P et al. Bifunctional Au-Fe3O4 nanoparticles for protein separation. ACS Nano 2007; 1:293–298 [View Article]
    [Google Scholar]
  28. DuBois M, Gilles KA, Hamilton JK, Rebers PA, Smith F. Colorimetric method for determination of sugars and related substances. Anal Chem 1956; 28:350–356 [View Article]
    [Google Scholar]
  29. Chaplin M. Chaplin M. F, Kennedy J. F. eds Monosaccharides in Carbohydrate Analysis: Practical Approach Oxford: IRL Press; 19861–36
    [Google Scholar]
  30. Buslov DK, Nikonenko NA. A Priori estimation of the parameters of the method of spectral curve deconvolution. Appl Spectrosc 1998; 52:613–620 [View Article]
    [Google Scholar]
  31. Haner RL, Keifer PA. Flow probes for NMR spectroscopy. eMagRes 2009
    [Google Scholar]
  32. Farjah A, Owlia P, Siadat SD, Mousavi SF, Ardestani MS et al. Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa . APMIS 2015; 123:175–183 [View Article]
    [Google Scholar]
  33. Kashef N, Behzadian-Nejad Q, Najar-Peerayeh S, Mousavi-Hosseini K, Moazzeni M et al. Synthesis and characterization of Pseudomonas aeruginosa alginate-tetanus toxoid conjugate. J Med Microbiol 2006; 55:1441–1446 [View Article]
    [Google Scholar]
  34. Park CY, Jung SH, Bak JP, Lee SS, Rhee DK. Comparison of the rabbit pyrogen test and Limulus amoebocyte lysate (LAL) assay for endotoxin in hepatitis B vaccines and the effect of aluminum hydroxide. Biologicals 2005; 33:145–151 [View Article]
    [Google Scholar]
  35. Amini V, Kazemian H, Yamchi JK, Feyisa SG, Aslani S et al. Evaluation of the immunogenicity of diphtheria toxoid conjugated to salmonella typhimurium-derived OPS in a mouse model: a potential vaccine candidate against salmonellosis. Iran Red Crescent Med J 2016; 18: [View Article]
    [Google Scholar]
  36. Ames P, DesJardins D, Pier GB. Opsonophagocytic killing activity of rabbit antibody to Pseudomonas aeruginosa mucoid exopolysaccharide. Infect Immun 1985; 49:281–285
    [Google Scholar]
  37. Ray A, Dittel BN. Isolation of mouse peritoneal cavity Cells. JoVE 2010; 35: [View Article]
    [Google Scholar]
  38. Hu BT, Yu X, Jones TR, Kirch C, Harris S et al. Approach to validating an opsonophagocytic assay for Streptococcus pneumoniae . Clin Diagn Lab Immunol 2005; 12:287–295 [View Article]
    [Google Scholar]
  39. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985; 22:996–1006
    [Google Scholar]
  40. Hell E, Giske CG, Hultenby K, Danielsson KG, Marchini G. Attachment and biofilm forming capabilities of Staphylococcus epidermidis strains isolated from preterm infants. Curr Microbiol 2013; 67:712–717 [View Article]
    [Google Scholar]
  41. McKenney D, Hübner J, Muller E, Wang Y, Goldmann DA et al. The ica locus of Staphylococcus epidermidis encodes production of the capsular polysaccharide/adhesin. Infect Immun 1998; 66:4711–4720
    [Google Scholar]
  42. Stepanović S, Vuković D, Hola V, Di Bonaventura G, Djukić S et al. Quantification of biofilm in microtiter plates: overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 2007; 115:891–899 [View Article]
    [Google Scholar]
  43. Sun D, Accavitti MA, Bryers JD. Inhibition of biofilm formation by monoclonal antibodies against Staphylococcus epidermidis RP62A accumulation-associated protein. Clin Diagn Lab Immunol 2005; 12:93–100 [View Article]
    [Google Scholar]
  44. Rabinovitch C, Stewart PS. Removal and inactivation of Staphylococcus epidermidis biofilms by electrolysis. Appl Environ Microbiol 2006; 72:6364–6366 [View Article]
    [Google Scholar]
  45. Spiliopoulou AI, Krevvata MI, Kolonitsiou F, Harris LG, Wilkinson TS et al. An extracellular Staphylococcus epidermidis polysaccharide: relation to Polysaccharide Intercellular Adhesin and its implication in phagocytosis. BMC Microbiol 2012; 12:76 [View Article]
    [Google Scholar]
  46. Campodónico VL, Llosa NJ, Bentancor LV, Maira-Litran T, Pier GB. Efficacy of a conjugate vaccine containing polymannuronic acid and flagellin against experimental Pseudomonas aeruginosa lung infection in mice. Infect Immun 2011; 79:3455–3464 [View Article]
    [Google Scholar]
  47. Theilacker C, Coleman FT, Mueschenborn S, Llosa N, Grout M et al. Construction and characterization of a Pseudomonas aeruginosa mucoid exopolysaccharide-alginate conjugate vaccine. Infect Immun 2003; 71:3875–3884 [View Article]
    [Google Scholar]
  48. Weidenmaier C, Lee JC. Structure and function of surface polysaccharides of Staphylococcus aureus ; 2015
  49. Gening ML, Maira-Litrán T, Kropec A, Skurnik D, Grout M et al. Synthetic β-(1->6)-linked N-acetylated and nonacetylated Oligoglucosamines used to produce conjugate vaccines for bacterial pathogens. Infect Immun 2010; 78:764–772 [View Article]
    [Google Scholar]
  50. Marrack P, McKee AS, Munks MW. Towards an understanding of the adjuvant action of aluminium. Nat Rev Immunol 2009; 9:287–293 [View Article]
    [Google Scholar]
/content/journal/jmm/10.1099/jmm.0.000910
Loading
/content/journal/jmm/10.1099/jmm.0.000910
Loading

Data & Media loading...

Supplements

Supplementary material 1

PDF
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error